A phase 2 study of Chronocort®, a modified release formulation of hydrocortisone, in the treatment of adults with classic congenital adrenal hyperplasia

Authors
Category Primary study
JournalEndocrine Reviews
Year 2014
This article has no abstract
Epistemonikos ID: fa859af5254e754cf64c6e69e6dd416f1ede0d4e
First added on: Feb 07, 2025